These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22949827)

  • 1. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
    Li W; Cai JH; Zhang J; Tang YX; Wan L
    Int J Mol Sci; 2012; 13(8):9741-9753. PubMed ID: 22949827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
    Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
    Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.
    Li W; Jiang HR; Xu XL; Wang J; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2010 Oct; 11(10):3999-4013. PubMed ID: 21152316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.
    Li W; Wang J; Jiang HR; Xu XL; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2011 Jan; 12(1):668-81. PubMed ID: 21340007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
    Li W; Wan L; Zhai LY; Wang J
    Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts.
    Li W; Tang YX; Wan L; Cai JH; Zhang J
    Oncol Lett; 2013 Mar; 5(3):923-928. PubMed ID: 23426648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
    Xu G; Wu K; Wang XP; Zhao S
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
    Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
    Zhang DQ; Guo Q; Zhu JH; Chen WC
    World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.
    Li W; Ji ZL; Zhuo GC; Xu RJ; Wang J; Jiang HR
    Med Oncol; 2010 Mar; 27(1):98-104. PubMed ID: 19235530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W; Yu CH; Hu KQ
    Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism].
    Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
    Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
    Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
    Shishodia S; Aggarwal BB
    Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
    Shin DM; Zhang H; Saba NF; Chen AY; Nannapaneni S; Amin AR; Müller S; Lewis M; Sica G; Kono S; Brandes JC; Grist WJ; Moreno-Williams R; Beitler JJ; Thomas SM; Chen Z; Shin HJ; Grandis JR; Khuri FR; Chen ZG
    Clin Cancer Res; 2013 Mar; 19(5):1244-56. PubMed ID: 23422093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
    Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
    Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.